The stimulants Ritalin and Adderall have been used to treat attention-deficit/hyperactivity disorder (ADHD) for decades, but ...

Sector is overwhelmed by demand and expanding faster than administrative structures can support ...

The delayed sleep-wake phase in adolescents often overlaps with ADHD and restless legs syndrome, worsening insomnia and ...

German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...

Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...

Exclusive: Total spending in England expected to double existing budgets, with funding for private providers rising threefold ...

Upstate Medical University will study the medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD) ...

Young adults today are digital natives-naturally fluent with devices and online platforms-so some of their most effective ...

Young adults today are digital natives—naturally fluent with devices and online platforms—so some of their most effective ...

“The stark reality for the vast majority of people in the non-Western world, transcending everything, is poverty. Currently ...

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...